Navigating COA Complexities for a Psoriatic Arthritis Trial

A biotechnology company and their contract research organization (CRO) partner leveraged Signant’s scale management and digital health sciences expertise to help navigate complexities related to clinical outcome assessment (COA) selection, acquisition, and implementation for a psoriatic arthritis (PsA) trial.

Learn how our clinical and eCOA expertise helped the sponsor launch on time and ensure a robust data capture strategy facilitated accurate patient- and clinician-reported endpoint data.